Research by the FDA (the US Food and Drug Administration) into the effects Meridia may have on cardiovascular risk have produced some startling results.

Originally authorised by the FDA in 1997 for use on obese patients who are at risk of developing heart disease and diabetes, their latest study dubbed SCOUT has found that Meridia (formulated from sibutramine) could in fact produce the opposite results.

Started in 2002, over 10,000 volunteers aged over 55 were placed either on a Meridia or placebo test – all of whom were obese/overweight with two cardiac risks factors (diabetes or a history of heart disease).

Yet this study did not go as planned…

From this study the FDA found cardiovascular events in 11.4% of patients who were placed on Meridia and a further 10% in those placed on the placebo – in both cases substantially more than they had anticipated.

Further data even suggested that Meridia could in fact increase a patient’s risk of experiencing a heart attack, a stroke or even death from taking this supplement.

Following such shocking results, it is now believed that Meridia is no longer appropriate for patients suffering from diabetes, heart disease or congestive heart failure, and anyone considering taking it should consult with a doctor first.

Is it bad for everyone?

Although this research published by the FDA would suggest that Meridia is not safe, these results only apply to obese patients who suffer from the above conditions.

As long you are young and relatively healthy, Meridia can help you to experience credible weight loss. However, it is still recommended that you first visit a physician and check your suitability to this supplement before you try it.